Faslodex

DRUG5 trials

Sponsors

Translational Oncology Research International, Mothaffar Rimawi, Hoffman Oncology, Assiut University, Medical College of Wisconsin

Conditions

Advanced Breast CancerBreast CancerMetastatic Breast CancerSolid Tumor

Phase 1

Phase I Study of Combination of Gedatolisib With Palbociclib and Faslodex in Patients With ER+/HER2- Breast Cancer

Hoffman OncologyBreast Cancer

Start: 2016-01-31End: 2022-03-15Target: 18Updated: 2022-02-09

Hydroxychloroquine, Abemaciclib and Endocrine Therapy in Hormone Receptor Positive (HR+)/Her 2 Negative Breast Cancer

WithdrawnNCT04316169

Medical College of WisconsinAdvanced Breast Cancer, Solid Tumor

Start: 2021-10-21End: 2028-01-31Updated: 2022-12-23

Phase 2

Fulvestrant and/or Trastuzumab as First-Line Therapy in Treating Postmenopausal Women With Stage IV Breast Cancer

TerminatedNCT00138125

Translational Oncology Research InternationalBreast Cancer

Start: 2005-04-30End: 2009-12-31Updated: 2020-10-19

Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer

CompletedNCT00570323

Mothaffar RimawiBreast Cancer

Start: 2007-12-31End: 2018-12-05Updated: 2020-07-28

Phase 4

Fulvestrant in Metastatic Breast Cancer

Assiut UniversityMetastatic Breast Cancer

Start: 2018-08-01End: 2021-10-01Target: 30Updated: 2018-07-23